Can you imagine needing medical care for your child but being unable to simply and safely take them to see a doctor? That's the case in low-and middle-income countries, where less than 30% of children with cancer survive due to unavailable or unaffordable treatment.
Our friend, supporter and advocate, Mark Crafts, passed away last week.
Mark was introduced to us in 2017 after being diagnosed with cancer. Since then, Mark remained a steadfast supporter in advancing Conquer Cancer's mission and leading many efforts to help raise funds for cancer research and vital programs.
ALEXANDRIA, Va. – Conquer Cancer®, the ASCO Foundation, is pleased to announce the recipients of its 2022 Quality Care Symposium Merit Awards.
These distinguished awards recognize oncology fellows and trainees who are first authors on top-ranking abstracts selected for presentation at the ASCO Quality Care Symposium September 30 – October 1, 2022, in Chicago.
These 30 oncology professionals are recognized for their respective field and research advancements within the cancer care community:
ALEXANDRIA, Va. - Conquer Cancer®, the ASCO Foundation, is pleased to announce Orit Kaidar-Person, MD, of Sheba Medical Center as the recipient of the 2022 Conquer Cancer - Israel Cancer Research Fund Career Development Award (CDA).
ALEXANDRIA, Va. - Conquer Cancer®, the ASCO Foundation, and the Melanoma Research Foundation (MRF) are pleased to announce Leslie K. Dennis, PhD, MS, of The University of Arizona, as the recipient of the 2022 ASCO Registry Melanoma Research Grant.
Conquer Cancer, the ASCO Foundation, has funded researchers at 47 of the 50 Best Cancer Hospitals for 2022.
The list, recently released by U.S. News & World Report, evaluates 914 hospitals and academic centers based on survival rates for particularly challenging patients, patient experience, and other measures of performance that can be assessed using hard data. The top 50 institutions that treat cancers such as leukemia, lymphoma, melanoma, breast, kidney, colon, prostate, pancreatic, head and neck, orthopedic, uterine, and ovarian cancers were ranked.